Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03165721
Title A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

gastrointestinal stromal tumor

extra-adrenal pheochromocytoma

renal cell carcinoma

leiomyomatosis

adrenal gland pheochromocytoma

paraganglioma

Therapies

Guadecitabine

Age Groups: adult | child | senior
Covered Countries USA

Additional content available in CKB BOOST